Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 14Lung Neoplasms 8Prostatic Neoplasms 6Colorectal Neoplasms 6Neoplasms 5Pancreatic Neoplasms 3Ovarian Neoplasms 3Lymphoma 3Smoking Cessation 2Skin Carcinoma 2Pain 2Melanoma 2Malignant Solid Neoplasm 2Leukemia, Myeloid, Acute 2Hematopoietic and Lymphatic System Neoplasm 2Carcinoma, Non-Small-Cell Lung 2Anatomic Stage I Breast Cancer AJCC v8 2Advanced Malignant Solid Neoplasm 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Smoking 1Testicular Neoplasms 1Spondylitis, Ankylosing 1Smoking 1Signs and Symptoms 1Sepsis 1Rectal Neoplasms 1Psoriasis 1

Interventions

Saline Solution 1Methods 1Hydrochloric Acid 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sepsis × Methods × 90 days × Clear all
NCT05376566 2026-03-24

Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections

Rigshospitalet, Denmark

Phase NA Completed
212 enrolled

Neoplasms, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡